Caribou Biosciences (CRBU) vs ImageneBio (IMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ImageneBio (IMA) has outperformed Caribou Biosciences (CRBU) over the past year, losing 44.7% versus a loss of 74.6%. Over five years, IMA leads with a -96.8% price change compared with -97.0% for CRBU. Caribou Biosciences is the larger company by market cap ($51.0 million vs $48.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRBU | IMA |
|---|---|---|
| Share price | $0.4756 | $4.28 |
| Market cap | $50.99M | $48.68M |
| 1-day change | -22.97% | -7.16% |
| YTD return | -61.17% | -33.19% |
| 1-year return | -74.59% | -44.72% |
| 5-year return | -97.04% | -96.83% |
| EPS (TTM) | $-1.08 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.54 | $9.10 |
| 52-week low | $0.4707 | $3.94 |
| Distance from 52-week high | -86.55% | -52.97% |
| Average volume | 1.87M | 12.81K |
| Shares outstanding | 107.21M | 11.37M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMA has outperformed CRBU by 29.9 percentage points over the past year.
CRBU vs IMA FAQ
Which is bigger, Caribou Biosciences or ImageneBio?
Caribou Biosciences (CRBU) is larger, with a market capitalization of $50.99M compared with $48.68M for ImageneBio (IMA).
Which stock has performed better over the past year, CRBU or IMA?
IMA returned -44.72% over the past 12 months, compared with -74.59% for CRBU (price return, excluding dividends). Past performance does not predict future results.
Are Caribou Biosciences and ImageneBio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.